2023 Payment for Drugs: Challenges & Opportunities - On Demand
This activity will discuss recently finalized and proposed rules for reimbursement from Centers for Medicare and Medicaid Services and how to locate newly approved NTAP drug payments for FY2023, as well as cover the updates that pertain to the reimbursement cycle. The session provides suggestions and tools for assessing current practice and making needed changes. It’s not only about money but about assuring data accuracy.
Pharmacists learning objectives
At the conclusion of this activity, pharmacists should be able to:
1. Discuss recently finalized (IPPS) and proposed (OPPS) rules for reimbursement from Centers for Medicare and Medicaid Services.
2. Identify how to locate newly approved NTAP drug payments for FY2023.
3. Identify drug payment requirements, the sources of information and personnel’s responsibilities in a cross-functional multidisciplinary approach to revenue cycle management.
Pharmacy technician learning objectives
At the conclusion of this activity, pharmacy technicians should be able to:
1. Develop strategies for ensuring accuracy, completeness of data submitted for reimbursement and analytic.
Carolyn Liptak, MBA, RPH
Pharmacy Executive Director
Bonnie Kirschenbaum, BScPharm, MS, FASHP, FCSHP
Jackie Stokes, BS
Manager, Pharmacy Program
Gretchen Brummel, PharmD, BCPS
Consulting Solutions Director
Identification, Mitigation, and Disclosure of Relevant Financial Relationships
As an accredited provider of continuing education, Vizient, Inc. is dedicated to ensuring this activity presents learners with only accurate, balanced, scientifically justified recommendations, and is free from promotion, marketing, and commercial bias. In accordance with The Standards for Integrity and Independence in Accredited Continuing Education, all planners, faculty, and others in control of the educational content have disclosed the absence or existence of all financial relationships (of any dollar amount) with ineligible companies within the past 24 months.
It is Vizient’s policy that owners and employees of ineligible companies, and any individuals who refuse to disclose the absence or existence of financial relationships with any ineligible companies are disqualified from participating as planners or faculty.
Disclosure of Financial Relationships:
Absence of Relevant Financial Relationships
Vizient, Inc., Jointly Accredited for Interprofessional Continuing Education, defines companies to be ineligible as those whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.
An individual is considered to have a relevant financial relationship if the educational content an individual can control is related to the business lines or products of the ineligible company.
No one in a position to control the content of this educational activity have relevant financial relationships with ineligible companies.
Statement of content validity
Vizient, Inc. educational activities are intended to assist healthcare teams advance their professional responsibilities in accordance with the definition of continuing education. It is the policy of Vizient, Inc. to review and ensure that all content and recommendations for patient care within accredited CE is evidenced-based, based on current science and clinical reasoning while ensuring the content is fair and balanced. All recommendations must conform to the generally accepted standards of experimental design, data collection, analysis, and interpretation. Vizient, Inc. does not permit accredited continuing education if it advocates for unscientific approaches to diagnosis or therapy, or if the education promotes recommendations, treatment, or manners of practicing healthcare that are determined to have risks or dangers that outweigh the benefits or are known to be ineffective in the treatment of patients.
In support of improving patient care, Vizient, Inc. is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.
Vizient, Inc. designates this activity for a maximum of 1.0 ACPE credit hours.
- 1.00 ACPE Pharmacist
- 1.00 ACPE Pharmacy Technician